Engels, Victoria (Kranus Health 202206 PR + Content Manager) |
Public Relations Manager / Investor Relations Manager |
Kranus Health (Group) |
Germany |
Engeser, Marianne (Uni Bonn 200910 Head Div of Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
Enghild, Jan J. (Aarhus Univ 201106 Professor Laboratory for Proteome Analysis and Protein Characterisation) |
Professor |
Aarhus University |
Denmark |
Enghofer, Erich (4SC 201406– EVP Oncology + Haematology before Bayer Healthcare) |
President/Director/Head Business Group/Unit/Division |
4SC (Group) |
Germany |
England, Claire (Covalent Bonds 2018– before Scott Partnership at Kapler Comms + Phoenix MarCom) |
Public Relations Manager / Investor Relations Manager |
Covalent Bonds LLC |
United States (USA) |
Englbrecht, Claudia (BIO Deutschland 2013 Public Relations Manager) |
public/private partnership |
BIO Deutschland e. V. |
Germany |
Engleman, Katie (1AB Media 201903 before Pure Communications) |
Public Relations Manager / Investor Relations Manager |
1AB Media (US) |
United States (USA) |
Englerth, Chris (Phlexglobal 202001 Head Global Marketing) |
Sales Manager / Marketing Manager |
Phlexglobal (Group) |
United Kingdom (GB) |
Engsig, Michael (Vaccibody 202010 CEO) |
Chief Executive Officer (CEO) |
Vaccibody AS (Euronext Growth Oslo: VACC) |
Norway |
Enns, Timothy L. (KineMed 201401– Chief Investor + Media Relations Officer before Astex/SuperGen) |
Public Relations Manager / Investor Relations Manager |
KineMed Inc. |
United States (USA) |
Ensthaler, Janna (Green Generation 202206 Managing Director + Co-Founder) |
Managing Director |
Green Generation (Group) |
Germany |
Enyedy, Mark J. (ImmunoGen 201705 CEO before Genzyme 200803 President Genzyme Oncology) |
Chief Executive Officer (CEO) |
AbbVie (Group) |
United States (USA) |
Enzelberger, Markus (Versant Ventures 202003– EIR in Basel before MorphoSys 2002–202002) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Versant Ventures |
Switzerland |
Epping-Jordan, Mark (Addex Pharma –200806 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Addex (Group) |
Switzerland |
Epstein, Barry (Proteomics International 201201 VP Marketing) |
Sales Manager / Marketing Manager |
Proteomics International Pty Ltd. |
Australia |
Epstein, David M. (Black Diamond Therapeutics 2017– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Black Diamond Therapeutics (Group) |
United States (USA) |
Epstein, David R. (Seagen 202211– CEO before Flagship Pioneering + more than 25 years at Novartis) |
Chief Executive Officer (CEO) |
Seagen (Group) |
United States (USA) |
Epstein, Jake (Klein Hersh International 202002 Director of Business Development + Finance) |
Business Development Manager / Strategy Manager |
Klein Hersh International |
United States (USA) |
Erbe, Cornelius (vfa 202001 Managing Director) |
Managing Director |
VFA (Verband Forschender Arzneimittelhersteller e. V.) |
Germany |
Erdman, Chris (CRISPR Therapeutics 201711 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
CRISPR Therapeutics (Group) |
United States (USA) |
Erdmann, Till (Myelo Therapeutics 201304– Managing Director) |
Managing Director |
Eckert & Ziegler (Group) |
Germany |
Erdmann, Winfried (Berthold Technologies 201106 European Sales Manager Bioanalytic) |
Sales Manager / Marketing Manager |
Berthold Technologies (Group) |
Germany |
Ergun, Elcin Baker (Menarini 201909– CEO before Merck (DE) 201409 Head Global Commerical at Merck Serono) |
Chief Executive Officer (CEO) |
Menarini (Group) |
Italy |
Erhard, Marcel (AnagnosTec 1998–200912– CSO + co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
AnagnosTec Gesellschaft für Analytische Biochemie und Diagnostik mbH |
Germany |
Erhart, Benjamin (High-Tech Gründerfonds 201204 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Eric Fotheringham (Waters 200601 Senior Product Manager) |
Product Manager (personnel) |
Waters (Group) |
Germany |
Erlen, Hubertus |
n. a. |
Bayer (Group) |
Germany |
Erlich, Henry (Roche 201103 Roche Molecular Systems Director of Dept of Human Genetics) |
Researcher (industry) |
Children’s Hospital Oakland |
United States (USA) |
Ermantraut, Eugen (Clondiag 200502 Managing Director) |
Managing Director |
Abbott (Group) |
Germany |
Ernst, Bettina (Bernina BioInvest 202011 Director + InterAx Biotech 201901– Non-executive Board Member) |
Board member, non-executive |
Bernina BioInvest AG |
Switzerland |
Ernst, Doreen (Analytik Jena 200809) |
n. a. |
Endress+Hauser (Group) |
Germany |
Ernst, Oliver (Neuway Pharma 202210 CEO + Managing Director) |
Chief Executive Officer (CEO) |
Neuway Pharma GmbH |
Germany |
Erselius, Jörn R. (Max Planck Innovation Managing Director before Garching Innovation 200311) |
Managing Director |
Max Planck Society for the Advancement of Science |
Germany |
Ertürk, Ali (Helmholzt Munich + LMU Munich + 1X1 Biotech) |
Professor |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
Erwin, M. Johnston (Eli Lilly 201603 VP Corporate Business Development) |
Business Development Manager / Strategy Manager |
Eli Lilly (Group) |
United States (USA) |
Eschenfelder, Christina (Rittershaus 201511 Lawyer) |
Attorney / Lawyer |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
Escher, Adrian (ESBATech 200205 CFO) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
Escher, Dominik (Belleveue 201001 Managing Partner at BB Pureos Bioventures before ESBATech CEO + Founder) |
Managing Partner |
Bellevue (Group) |
United Kingdom (GB) |
Escher, Klaus |
n. a. |
BASF (Group) |
Germany |
Esper, Ralph (Eppendorf 201811– Head of Corporate Communications before Hagebau + Hamburger Sparkasse) |
Public Relations Manager / Investor Relations Manager |
Eppendorf (Group) |
Germany |
Espinet, Antoine Jean (MicrofluidX 201810– CEO + Founder) |
Chief Executive Officer (CEO) |
MicrofluidX Ltd. |
United Kingdom (GB) |
Esposito, Gloria (Artemis 200705– Project Manager) |
n. a. |
Taconic (Group) |
Germany |
Essakali, Salim (Solis BioDyne 202109– Head of Global Sales + Marketing before Qiagen + Boston Scientific) |
Sales Manager / Marketing Manager |
Solis BioDyne OÜ |
Estonia |
Essenpreis, Matthias (Roche 201502 CTO of Roche Diagnostics) |
Chief Technology/Technical Officer (CTO) |
Roche (Group) |
United States (USA) |
Esser, Karen (Potsdam Science Park 202305 PR + Communications) |
Public Relations Manager / Investor Relations Manager |
Potsdam Science Park (Standortmanagement Golm GmbH) |
Germany |
Esser, Marc (Co.faktor 202309 Managing Director (CEO) + Founder) |
Managing Director |
Cytel (Group) |
Germany |
Essig, Stuart M. (Wellington Partners 201303– Venture Partner before Integra Life Sciences CEO + Goldman Sachs) |
Venture Partner |
Wellington Partners (Group) |
Germany |
Essinger, Jacques R. (Symetis 201703 CEO) |
Chief Executive Officer (CEO) |
Boston Scientific (Group) |
Switzerland |
Esslinger, Christoph (Memo Therapeutics AG 202011 CSO + Co-Founder formerly CEO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Memo Therapeutics AG (MTx) |
Switzerland |
Estafanos, Roger (ITM 202304– General Manager US before Advanced Accelerator Applications) |
General Manager (management) |
ITM (Group) |
United States (USA) |
Esther, Michael (Sysmex 202402 President + CEO of Sysmex Partec GmbH) |
Managing Director |
Sysmex (Group) |
Germany |
Etches, Robert J. (Rob) (Crystal Bioscience 201401 CEO) |
Chief Executive Officer (CEO) |
Crystal Bioscience Inc. |
United States (USA) |
Ettenberg, Seth (Bayer 202003– CSO BlueRock Therapeutics before Unum Therapeutics + Novartis IBR + CuraGen) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Bayer (Group) |
United States (USA) |
Etzold, Thure (Lion Bioscience 200502–200604 CEO resigned) |
Chief Executive Officer (CEO) |
2invest (Group) |
Germany |
Eugster, Rudolf (Tecan 200212–20203 CFO RETIRED 3/20) |
Chief Financial Officer (CFO) |
Tecan (Group) |
Switzerland |
Eul, Wilfried (Evonik 201207 SVP + Head Catalysts Business Line) |
President/Director/Head Business Group/Unit/Division |
Evonik (Group) |
Germany |
Euller, Gordon (Apex Ventures 202010 Partner Digital Health) |
Partner (venture partner) |
Apex Ventures (Group) |
Austria |
Evans, David (Roche 202305 Investment Director at Roche Venture Fund) |
Investment Manager |
Roche (Group) |
Switzerland |
Evans, David (Syngenta 200404) |
n. a. |
Syngenta (Group) |
Switzerland |
Evans, Richard (EKF Diagnostics 201307– COO before Finance Director) |
Chief Operating Officer (COO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
Evans, Thomas G. (Tom) (Vaccitech 201908– CSO before CEO before Vical + Novartis + Aeras) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Vaccitech (Group) |
United Kingdom (GB) |
Evans-Freke, Stephen (Celtic Therapeutics 2007 General Partner + Co-Founder) |
General Partner (venture partner) |
Auven Therapeutics (Group) |
United States (USA) |
Evenden, Anja (Vego Ltd 201401 Marketing Executive) |
Sales Manager / Marketing Manager |
Vego Ltd. |
United Kingdom (GB) |
Evens, Andrew (Tufts University 201601 Prof at Tufts Univ School of Medicine + Director of Cancer Center) |
Professor |
Affimed (Group) |
Germany |
Evers, Matthias (Evotec 202306 CBO before McKinsey & Co) |
Chief Business Officer (CBO) |
Evotec (Group) |
Germany |
Everson, Lloyd (MolecularHealth 201401 CEO of US division before US Oncology Inc) |
Chief Executive Officer (CEO) |
Molecular Health (Group) |
United States (USA) |
Evertsz, Carl J. G. (MeVis Medical Solutions 200609–201202 CEO LEAVES 3/12) |
Chief Executive Officer (CEO) |
Varian Medical Systems (Group) |
Germany |
Evnin, Luke (MPM Capital 201307 Managing Director) |
Managing Director |
MPM Capital (Group) |
United States (USA) |
Ewert, Markus L. E. (Alentis Therapeutics 201904–202007 CEO before Ablynx+ GE Healthcare + Novartis + BC LEFT 7/20) |
Chief Executive Officer (CEO) |
Alentis Therapeutics AG |
Switzerland |
Eyber, Klaus U. (Kaye Scholer 200407– Attorney + Partner at Kay Scholer in Ffm before Haarmann Hemmelrath) |
Attorney / Lawyer |
Arnold & Porter LLP |
Germany |
Eylenbosch, Hilde (Biocartis 201611–201904 CCO joined 2013 before Alere + SPD Swiss Precision LEFT 5/19) |
Chief Commercial Officer (CCO) |
Biocartis (Group) |
Belgium |
Ezickson, Elan (Aveo Pharmaceuticals 201112 CBO) |
Chief Business Officer (CBO) |
Aveo Pharmaceuticals Inc. |
United States (USA) |
Faber, Christian Jörg (Alytas Therapeutics 201808– Managing Director) |
Managing Director |
Alytas Therapeutics GmbH |
Germany |
Fáber, René (Sartorius 202010 Head of Bioprocess Solutions Division) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
Fabro, Scott (Evolva 20107– CCO before Sweet Harvest Foods + ACH Foods + Kerry + Cargill) |
Chief Commercial Officer (CCO) |
Lallemand (Group) |
Switzerland |
Fackler, Thomas |
n. a. |
Fraunhofer (Group) |
Germany |
Faeh, Urban (Bruker 201001– President Bruker Optics division joined Bruker 1998 as sales manager) |
President/Director/Head Business Group/Unit/Division |
Bruker BioSciences (Group) |
|
Fafflock, Heike (Bremen 201005– Innovation Manager Health before B.I.T. + hkk) |
n. a. |
Bremen (govt region) |
Germany |
Fagan, Maria (Regulatory and Quality Solutions 202009 President + Co-Founder) |
Chief Executive Officer (CEO) |
Regulatory and Quality Solutions (R&G) (Group) |
United States (USA) |
Fagerberg, Jan (Enterome 202103 CMO formerly Micromet 200911 SVP + CMO) |
Chief Medical Officer (CMO) |
Enterome S.A. |
France |
Faguer, Antoine (ArchiMed 202210 Partner) |
Partner (venture partner) |
ArchiMed (Group) |
France |
Fahr, Anne-Marie (Labor Limbach 200909 Head Microbiology) |
Laboratory Manager (industry) |
Labor Limbach (Group) |
Germany |
Fahrenberg, Jens (Karlsruhe Institute of Technology 201307 Head of Innovation Management Office) |
IP Manager |
Karlsruhe Institute of Technology (KIT) |
Germany |
Fairey, William (Bill) (MyoKardia 201901– CCO before ChemoCentryx + Actelion + Parke-Davis Pharmaceuticals US) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
Faisst, Arne-Christian (ABC Biopply 202106 CEO + Quadira Biosciences 202106 CEO) |
Chief Executive Officer (CEO) |
ABC Biopply AG |
Switzerland |
Fakih, Sarah (CureVac 202007– VP Investor Relations before MorphoSys + Qiagen) |
Public Relations Manager / Investor Relations Manager |
CureVac (Group) |
Germany |
Falcenberg, Matthias (Forbion 201604– Analyst at Munich Office before at MPI of Biochemistry) |
Analyst (Financial / Industry) |
Forbion (Group) |
Germany |
Falch, Siegfried (JEOL 201002 Managing Director JEOL (Germany) GmbH) |
Managing Director |
JEOL (Group) |
Germany |
Falchuk, Jason (BioBridges 201709 President + Founding Partner) |
President/Director/Head Business Group/Unit/Division |
Adecco (Group) |
United States (USA) |
Falk, Ursula (Dr Falk Pharma 201403 Managing Director) |
Managing Director |
Dr. Falk Pharma (Group) |
Germany |
Falken, Ulrich (Analyticon Biotechnologies 2007 COO) |
Chief Operating Officer (COO) |
Analyticon Biotechnologies AG |
Germany |
Falkstedt (formerly Santoni), Marjut (EU (govt) 202301– Chief Executive of European Investment Fund joined EU 1996) |
Chief Executive Officer (CEO) |
EU (govt) |
Luxembourg |
Fallegger, Florian (Neurosoft Bioelectronics 202103 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Neurosoft Bioelectronics (CH) |
Switzerland |
Fallen, Karen (Touchlight 202010– CEO of Touchlight DNA Servcies before Lonza + Celltech) |
Chief Executive Officer (CEO) |
Touchlight (Group) |
United Kingdom (GB) |
Fambrough, Douglas M. (Dicerna Pharmaceuticals 201711 CEO) |
Chief Executive Officer (CEO) |
Dicerna Pharmaceuticals Inc. (Nasdaq: DRNA) |
United States (USA) |
Fang, Guowei (GenScript 202311 CSO + Head of Business Development at Legend Biotech) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
GenScript (Group) |
United Kingdom (GB) |
Fang, Nan (Singleron 202203 CEO + Co-Founder before Novogene + Qiagen) |
Chief Executive Officer (CEO) |
Singleron (Group) |
China |
Fang, Peter (Boehringer 202002 SVP + Head of Therapeutic Area Inflammation) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
Fang, Yongliang (Doer Biologics 202307 COO) |
Chief Operating Officer (COO) |
Doer Biologics (Group) |
China |
Faraco, Vincenza (University of Naples Federico II 201405) |
Researcher (university / research institute) |
University of Naples Federico II |
Italy |